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Purpose
The effect of basal-bolus insulin therapy on better glyce-
mic control was documented in the DCCT study. We
aimed to clarify whether the introduction of insulin ana-
logues gave the good quality of life using basal-bolus
insulin therapy without hypoglycemia to the most of
pediatric and adolescent patients with type 1 diabetes
mellitus (T1DM).
Methods
Glycemic control was compared between the 1st in
1995, 2nd in 2000 and 3rd in 2008 cohorts of child-
hood-onset T1DM in Japan, consisting of 566, 749 and
803 patients, respectively. We examined the data of
HbA1c, frequency of moderately severe hypoglycemia,
insulin regimen, body mass index (BMI) and the SD
score each during July and October.
Results
The median values of HbA1c (% of glycemic goal <7.5%)
were significantly improved between the subsequent
three cohorts; 9.02% (18.6%), 8.10% (30.35) and 7.60%
(44.1%), in 1st, 2nd and 3rd cohorts, respectively. In
addition patients with HbA1c more than 9% were signif-
icantly decreased in that order of cohorts. The fre-
quency of moderately severe hypoglycemia was 9 times/
4 months/ 100 patients in 3rd cohort. The frequencies
of multiple daily insulin or pump therapy were 34.5%,
59.7% and 80.7%, in that order. The daily insulin dose
was higher in 3rd cohort in comparison with 1st cohort.
While the height SD score significantly increased in 3rd
cohort, the BMI SD scores in 2nd and 3rd cohorts were
significantly higher than that in 1st cohort.
Conclusion
We conclude that the introduction of insulin analogues,
especially using the long-acting analogues since 2003,
resulted in better glycemic control with good quality of
life with less moderately severe hypoglycemic episodes
in comparison with DCCT study. On the other hand we
may have to pay attention to overweight without dietary
advice.
On behalf of The Japanese Study Group of Insulin
Therapy for Childhood and Adolescent Diabetes.
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